BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6535365)

  • 1. Management to prevent high-sited recurrence of pharyngo-laryngeal cancers.
    Remacle M; Robillard T; Deckers C; Mazy G; Hamoir M; Van de Eeckhaut J
    Acta Otorhinolaryngol Belg; 1984; 38(5):464-73. PubMed ID: 6535365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary treatment of carcinoma of oropharynx and hypopharynx: principles and EORTC studies.
    Snow GB
    Sonderb Strahlenther Onkol; 1987; 81():127-34. PubMed ID: 3547724
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of squamous cell carcinoma of the pyriform sinus.
    Pesavento G; Ferlito A
    Acta Otorhinolaryngol Belg; 1984; 38(2):156-63. PubMed ID: 6485766
    [No Abstract]   [Full Text] [Related]  

  • 4. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review.
    Bova R; Goh R; Poulson M; Coman WB
    Laryngoscope; 2005 May; 115(5):864-9. PubMed ID: 15867655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of advanced hypopharyngeal carcinoma].
    Rauchfuss A; Koch U
    Strahlenther Onkol; 1987 Aug; 163(8):525-8. PubMed ID: 3629467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma of the oropharynx and hypopharynx.
    Lin DT; Cohen SM; Coppit GL; Burkey BB
    Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
    Deitmer T; Urbanitz D
    Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):7-10. PubMed ID: 2419720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems in treating early cases of head and neck cancer].
    Hirano M
    Gan No Rinsho; 1984 May; 30(6 Suppl):617-23. PubMed ID: 6748233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total pharyngolaryngoesophagectomy. Indications and results apropos of 17 cases].
    Borie D; Hannoun L; Tiret E; Chabolle F; Nordlinger B; Frileux P; Parc R
    Ann Chir; 1992; 46(4):297-302. PubMed ID: 1610082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oro- and hypopharyngeal cancer: the Basle concept of therapy].
    Wey W; Hünig R; Roth J; Walther E
    Sonderb Strahlenther Onkol; 1987; 81():48-55. PubMed ID: 3824132
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
    Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
    Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoma of the hypopharynx: reconstruction of the pharyngo-esophageal tract after circular pharyngectomy by the transplantation of a U-shaped jejunal loop to the neck].
    Filippetti M; Graziano F; Santoro E; Marzetti F; Germain MA; Julieron N
    Chir Ital; 1999; 51(3):193-8. PubMed ID: 10793764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics and significance of immunoglobulin E (IgE) as an immunological parameter in squamous cell carcinomas of the oral cavity and pharynx].
    Mayer BA; Enzmann H
    Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):316-9. PubMed ID: 3626713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of carcinoma of the oropharynx.
    Gluckman JL; Zitsch RP
    Oncology (Williston Park); 1990 Apr; 4(4):23-30; discussion 32, 34, 43. PubMed ID: 2143928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exclusive radiotherapy and radiotherapy-intra-arterial chemotherapy combination in the treatment of advanced cancer of the oropharynx. Retrospective study of 126 cases].
    de Carvalho MB; Kowalski LP; Andrade Sobrinko J; Rapoport A; Fava AS; Kanda JL; Góis Filho JF; Chagas JF
    Rev Laryngol Otol Rhinol (Bord); 1986; 107(2):119-25. PubMed ID: 3775126
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vincristine-bleomycin-methotrexate in the treatment of recurrence of ORL carcinoma].
    Airoldi M; Pedani F; Gabriell P; Giordano C; Pia F
    Acta Otorhinolaryngol Ital; 1988; 8(2):125-31. PubMed ID: 2461045
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.
    Laterza E; Mosciaro O; Urso US; Inaspettato G; Cordiano C
    Hepatogastroenterology; 1994 Jun; 41(3):278-82. PubMed ID: 7959554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preservation of laryngeal function in surgical treatment of hypopharyngeal carcinoma].
    Wang T; Li X; Yu Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 34(4):197-200. PubMed ID: 12764769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
    Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
    Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.